The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions
Abstract
Reverse immunogenetic approaches attempt to optimize the selection of candidate epitopes, and thus minimize the experimental effort needed to identify new epitopes. When predicting cytotoxic T cell epitopes, the main focus has been on the highly specific MHC class I binding event. Methods have also been developed for predicting the antigen-processing steps preceding MHC class I binding, including proteasomal cleavage and transporter associated with antigen processing (TAP) transport efficiency. Here, we use a dataset obtained from the SYFPEITHI database to show that a method integrating predictions of MHC class I binding affinity, TAP transport efficiency, and C-terminal proteasomal cleavage outperforms any of the individual methods. Using an independent evaluation dataset of HIV epitopes from the Los Alamos database, the validity of the integrated method is confirmed. The performance of the integrated method is found to be significantly higher than that of the two publicly available prediction methods BIMAS and SYFPEITHI. To identify 85% of the epitopes in the HIV dataset, 9% and 10% of all possible nonamers in the HIV proteins must be tested when using the BIMAS and SYFPEITHI methods, respectively, for the selection of candidate epitopes. This number is reduced to 7% when using the integrated method. In practical terms, this means that the experimental effort needed to identify an epitope in a hypothetical protein with 85% probability is reduced by 20-30% when using the integrated method. The method is available at http://www.cbs.dtu.dk/services/NetCTL. Supplementary material is available at http://www.cbs.dtu.dk/suppl/immunology/CTL.php.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring the Accuracy of Diagnostic Systems
Swets, J. A. (1988) · Science · doi:10.1126/science.3287615 · Cited by 10,058
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Parker, K. C., Bednarek, M. A., & Coligan, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.163 · Cited by 1,370
Reliable prediction of T‐cell epitopes using neural networks with novel sequence representations
Nielsen, M., Lundegaard, C., Worning, P., Lauemøller, S. L., Lamberth, K., Buus, S., Brunak, S., & Lund, O. (2003) · Protein Science · doi:10.1110/ps.0239403 · Cited by 1,074
Self-citationIMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
Yewdell, J. W., & Bennink, J. R. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.51 · Cited by 944
Sturniolo, T., Bono, E., Ding, J., Raddrizzani, L., Tuereci, O., Sahin, U., Braxenthaler, M., Gallazzi, F., Protti, M. P., Sinigaglia, F., et al. (1999) · Nature Biotechnology · doi:10.1038/9858 · Cited by 743
Nielsen, M., Lundegaard, C., Lund, O., & Keşmir, C. (2005) · Immunogenetics · doi:10.1007/s00251-005-0781-7 · Cited by 491
Self-citationIdentifying MHC Class I Epitopes by Predicting the TAP Transport Efficiency of Epitope Precursors
Peters, B., Bulik, S., Tampe, R., van Endert, P. M., & Holzhütter, H.-G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1741 · Cited by 339
MHC Ligands and Peptide Motifs
Rammensee, H.-G., Bachmann, J., & Stevanović, S. (1997) · Molecular Biology Intelligence Unit · doi:10.1007/978-3-662-22162-4 · Cited by 331
Buus, S., Lauemøller, S. L., Worning, P., Kesmir, C., Frimurer, T., Corbet, S., Fomsgaard, A., Hilden, J., Holm, A., & Brunak, S. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00112.x · Cited by 329
Self-citationDefinition of supertypes for HLA molecules using clustering of specificity matrices
Lund, O., Nielsen, M., Kesmir, C., Petersen, A. G., R�der, G., Justesen, S., Lundegaard, C., Worning, P., Sylvester-Hvid, C., Lamberth, K., et al. (2004) · Immunogenetics · doi:10.1007/s00251-004-0647-4 · Cited by 292
Self-citationPrediction of proteasome cleavage motifs by neural networks
Keşmir, C., Nussbaum, A. K., Schild, H., Detours, V., & Brunak, S. (2002) · Protein Engineering, Design and Selection · doi:10.1093/protein/15.4.287 · Cited by 282
Self-citationImproved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach
Nielsen, M., Lundegaard, C., Worning, P., Hvid, C. S., Lamberth, K., Buus, S., Brunak, S., & Lund, O. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth100 · Cited by 278
Self-citationCraiu, A., Akopian, T., Goldberg, A., & Rock, K. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10850 · Cited by 264
Two new proteases in the MHC class I processing pathway
Stoltze, L., Schirle, M., Schwarz, G., Schröter, C., Thompson, M. W., Hersh, L. B., Kalbacher, H., Stevanovic, S., Rammensee, H.-G., & Schild, H. (2000) · Nature Immunology · doi:10.1038/80852 · Cited by 249
HLA supertypes and supermotifs: a functional perspective on HLA polymorphism
Sette, A., & Sidney, J. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80124-6 · Cited by 243
The peptide-binding motif for the human transporter associated with antigen processing.
van Endert, P. M., Riganelli, D., Greco, G., Fleischhauer, K., Sidney, J., Sette, A., & Bach, J. F. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1883 · Cited by 181
Distinct Proteolytic Processes Generate the C and N Termini of MHC Class I-Binding Peptides
Mo, X. Y., Cascio, P., Lemerise, K., Goldberg, A. L., & Rock, K. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5851 · Cited by 142
Paz, P., Brouwenstijn, N., Perry, R., & Shastri, N. (1999) · Immunity · doi:10.1016/s1074-7613(00)80099-0 · Cited by 120
MAPPP: MHC class I antigenic peptide processing prediction.
Hakenberg, J., Nussbaum, A. K., Schild, H., et al. (2003) · PubMed · Cited by 111
Lévy, F., Burri, L., Morel, S., Peitrequin, A.-L., Lévy, N., Bachi, A., Hellman, U., den Eynde, B. J. V., & Servis, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4161 · Cited by 88
Altuvia, Y., & Margalit, H. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3392 · Cited by 57
A Neural Network Model Approach to the Study of Human TAP Transporter
Brusić, V., Endert, P. V., Zeleznikow, J., Daniel, S., Hammer, J., & Petrovsky, N. (1999) · In Silico Biology · doi:10.3233/isb-00010 · Cited by 52
Cited by
Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction
Larsen, M. V., Lundegaard, C., Lamberth, K., Buus, S., Lund, O., & Nielsen, M. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-424 · Cited by 982
Self-citationFundamentals and Methods for T- and B-Cell Epitope Prediction
Sanchez-Trincado, J. L., Gomez-Perosanz, M., & Reche, P. A. (2017) · Journal of Immunology Research · doi:10.1155/2017/2680160 · Cited by 674
Schumacher, T. N., Scheper, W., & Kvistborg, P. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053402 · Cited by 574
The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design
Fleri, W., Paul, S., Dhanda, S. K., Mahajan, S., Xu, X., Peters, B., & Sette, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00278 · Cited by 500
An overview of bioinformatics tools for epitope prediction: Implications on vaccine development
Soria-Guerra, R. E., Nieto-Gomez, R., Govea-Alonso, D. O., & Rosales-Mendoza, S. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2014.11.003 · Cited by 445
Metadata
- Authors
- Larsen, M. V., Lundegaard, C., Lamberth, K., Buus, S., Brunak, S., Lund, O., & Nielsen, M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2005-08
- Volume
- 35
- Issue
- 8
- Pages
- 2295-2303
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2142831360
- Cited by
- 313
- References
- 23
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.